格萊克生物科技有限公司
。市場Glac PRONEX® 技術保證作為益生菌產品製造商提供安全、高品質的益生菌和後生元成分/產品,例如 Pronulife® 混合益生菌
、Totipro® 後生元和各種功能單性菌株益生菌。國際標準規格和PRIMETEK®技術的工廠,為全球客戶提供全面的服務,包括原料和合約製造。
| Sales markets | Asia; Australia; Central/South America; Eastern Europe; North America; Western Europe |
|---|---|
| Primary business activity | Manufacturer: Ingredients / Additives |
| Affiliated categories: | Other Microorganisms & Probiotics |Other Prebiotics |Biotic products More |

17 Oct 2023
New Proud Achievement in the World of Postbiotics! Totipro®Postbiotics PE0401 has earned recognition as the FIRST in the world to excel in the "Ingredient: Microbiome Modulation" category, specifically for gastrointestinal function enhancement!
Read more26 Apr 2023
Postbiotics, which consist of inanimate microorganisms and their metabolites, have become a validated class of ingredients supported by a large amount of science evidence showing similar outcomes to probiotics without the challenges of thermo-limitation. Glac Biotech, a contract manufacturer at the forefront of postbiotics in Taiwan, has been able to launch clinically proven ingredients:Totipro® PE0301(Oral Health) and Totipro® PE0401(Inte...
Read more24 Apr 2023
Glac are thrilled to announce that our human breast milk-derived probiotic Bifidobacterium animalis subsp. Lactis CP-9 has been selected as a finalist in the NutraIngredient Awards Europe 2023: Weight Management category!
Read more